🎉 Excited to share that our team was awarded NAIRR support with Microsoft Azure credits to power our AI research! Big thanks to the National AI Research Resource Pilot and Microsoft for the compute resources that will help accelerate our work. 🚀
nairrpilot.org/projects/awa...

🧠 Join us Wed, Feb 4 at 12:30pm for a talk organized by the @harvardbrainsci.bsky.social - "The Nose as a Window Into the Brain" at HMS. Dr. Mark Albers and patient James Carney discuss nasal biomarkers & brain health. Lunch provided!

The annual Albers Lab winter get-together last weekend was a great success - wonderful conversations, great company, and a perfect way to celebrate the season.

Laura König, PhD candidate in the Albers Lab, was invited to present her work on TYK2 as a novel drug target in neurodegeneration at the 36th International Symposium on ALS/MND in San Diego (Dec 5–7, 2025). We thank the organizers and research community for the engaging discussions and interest.

"Antihypertensive drug repurposing for dementia prevention: a target trial emulation in a large-scale electronic health record system"

"Feasibility of a Novel Nasal Swab Test in Current and Recovered Chemosensory Dysfunction Associated with Long-COVID"

Poster titles:
"TYK2 kinase as a novel therapeutic target in Alzheimer’s Disease"

This week, Albers Lab members attended the annual Mass General Brigham Neurology Research Retreat and shared exciting lab projects. Congrats to PhD candidate Laura König, whose poster on TYK2 in neurodegenerative disease was awarded Best Poster! 👏🧠

Investigating Primary Care Indications to Improve the Quality of Electronic Health Record Data in Target Trial Emulation for Dementia Missing data, inaccuracies in medication lists, and recording delays in electronic health records (EHR) are major limitations for target trial emulation (TTE), which uses EHR data to retrospectively e...

Our CHIL 2025 paper reveals that data quality in the MGB EHR is elevated for patients with an MGB PCP. Through a sensitivity analysis on the use of a PCP variable in a study on the impact of antidiabetic drugs on dementia, we demonstrate the importance of considering PCP status in pragmatic trials.

Our work featured in Advances in Motion

#Alzheimers #MGH #SmellTest #Dementia #MCI #LongCovid advances.massgeneral.org/neuro/journa...

Using your nose to detect Alzheimer's, other memory disorders MGH researcher introduces at-home test to screen patients

Here is an article with a video published by WCVB about our at-home smell test for detecting Alzheimer's Disease and other memory disorders even up to two decades before onset! Thank you, WCVB, for featuring us! www.wcvb.com/article/usin...